These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 32485898)

  • 1. Subcutaneous Administration of Apolipoprotein J-Derived Mimetic Peptide d-[113-122]apoJ Improves LDL and HDL Function and Prevents Atherosclerosis in LDLR-KO Mice.
    Rivas-Urbina A; Rull A; Aldana-Ramos J; Santos D; Puig N; Farre-Cabrerizo N; Benitez S; Perez A; de Gonzalo-Calvo D; Escola-Gil JC; Julve J; Ordoñez-Llanos J; Sanchez-Quesada JL
    Biomolecules; 2020 May; 10(6):. PubMed ID: 32485898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low-density lipoprotein aggregation is inhibited by apolipoprotein J-derived mimetic peptide D-[113-122]apoJ.
    Rivas-Urbina A; Rull A; Montoliu-Gaya L; Pérez-Cuellar M; Ordóñez-Llanos J; Villegas S; Sánchez-Quesada JL
    Biochim Biophys Acta Mol Cell Biol Lipids; 2020 Feb; 1865(2):158541. PubMed ID: 31672573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mildly oxidized LDL induces an increased apolipoprotein J/paraoxonase ratio.
    Navab M; Hama-Levy S; Van Lenten BJ; Fonarow GC; Cardinez CJ; Castellani LW; Brennan ML; Lusis AJ; Fogelman AM; La Du BN
    J Clin Invest; 1997 Apr; 99(8):2005-19. PubMed ID: 9109446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An oral apoJ peptide renders HDL antiinflammatory in mice and monkeys and dramatically reduces atherosclerosis in apolipoprotein E-null mice.
    Navab M; Anantharamaiah GM; Reddy ST; Van Lenten BJ; Wagner AC; Hama S; Hough G; Bachini E; Garber DW; Mishra VK; Palgunachari MN; Fogelman AM
    Arterioscler Thromb Vasc Biol; 2005 Sep; 25(9):1932-7. PubMed ID: 15961700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ambient ultrafine particles alter lipid metabolism and HDL anti-oxidant capacity in LDLR-null mice.
    Li R; Navab M; Pakbin P; Ning Z; Navab K; Hough G; Morgan TE; Finch CE; Araujo JA; Fogelman AM; Sioutas C; Hsiai T
    J Lipid Res; 2013 Jun; 54(6):1608-1615. PubMed ID: 23564731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Procollagen C-endopeptidase Enhancer Protein 2 (PCPE2) Reduces Atherosclerosis in Mice by Enhancing Scavenger Receptor Class B1 (SR-BI)-mediated High-density Lipoprotein (HDL)-Cholesteryl Ester Uptake.
    Pollard RD; Blesso CN; Zabalawi M; Fulp B; Gerelus M; Zhu X; Lyons EW; Nuradin N; Francone OL; Li XA; Sahoo D; Thomas MJ; Sorci-Thomas MG
    J Biol Chem; 2015 Jun; 290(25):15496-15511. PubMed ID: 25947382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cholesterol reduction and atherosclerosis inhibition by bezafibrate in low-density lipoprotein receptor knockout mice.
    Inaba T; Yagyu H; Itabashi N; Tazoe F; Fujita N; Nagashima S; Okada K; Okazaki M; Furukawa Y; Ishibashi S
    Hypertens Res; 2008 May; 31(5):999-1005. PubMed ID: 18712055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regression and stabilization of advanced murine atherosclerotic lesions: a comparison of LDL lowering and HDL raising gene transfer strategies.
    Van Craeyveld E; Gordts SC; Nefyodova E; Jacobs F; De Geest B
    J Mol Med (Berl); 2011 Jun; 89(6):555-67. PubMed ID: 21249329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased low-density lipoprotein oxidation and impaired high-density lipoprotein antioxidant defense are associated with increased macrophage homing and atherosclerosis in dyslipidemic obese mice: LCAT gene transfer decreases atherosclerosis.
    Mertens A; Verhamme P; Bielicki JK; Phillips MC; Quarck R; Verreth W; Stengel D; Ninio E; Navab M; Mackness B; Mackness M; Holvoet P
    Circulation; 2003 Apr; 107(12):1640-6. PubMed ID: 12668499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new synthetic class A amphipathic peptide analogue protects mice from diet-induced atherosclerosis.
    Garber DW; Datta G; Chaddha M; Palgunachari MN; Hama SY; Navab M; Fogelman AM; Segrest JP; Anantharamaiah GM
    J Lipid Res; 2001 Apr; 42(4):545-52. PubMed ID: 11290826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of low-density lipoprotein catabolism by primary cultures of hepatic cells from normal and low-density lipoprotein receptor knockout mice.
    Truong TQ; Auger A; Denizeau F; Brissette L
    Biochim Biophys Acta; 2000 Apr; 1484(2-3):307-15. PubMed ID: 10760479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low and high density lipoprotein metabolism in primary cultures of hepatic cells from normal and apolipoprotein E knockout mice.
    Auger A; Truong TQ; Rhainds D; Lapointe J; Letarte F; Brissette L
    Eur J Biochem; 2001 Apr; 268(8):2322-30. PubMed ID: 11298750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deficiency of circadian gene cryptochromes in bone marrow-derived cells protects against atherosclerosis in LDLR
    Lin YS; Tsai ML; Hsieh IC; Wen MS; Wang CY
    FASEB J; 2021 Feb; 35(2):e21309. PubMed ID: 33423309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sphingosine-1-Phosphate Receptor 1, Expressed in Myeloid Cells, Slows Diet-Induced Atherosclerosis and Protects against Macrophage Apoptosis in Ldlr KO Mice.
    Gonzalez L; Qian AS; Tahir U; Yu P; Trigatti BL
    Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29244772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination therapy with cilostazol and pravastatin improves antiatherogenic effects in low-density lipoprotein receptor knockout mice.
    Park KY; Heo TH
    Cardiovasc Ther; 2018 Dec; 36(6):e12476. PubMed ID: 30378752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyodeoxycholic acid improves HDL function and inhibits atherosclerotic lesion formation in LDLR-knockout mice.
    Shih DM; Shaposhnik Z; Meng Y; Rosales M; Wang X; Wu J; Ratiner B; Zadini F; Zadini G; Lusis AJ
    FASEB J; 2013 Sep; 27(9):3805-17. PubMed ID: 23752203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ABCA1 overexpression in the liver of LDLr-KO mice leads to accumulation of pro-atherogenic lipoproteins and enhanced atherosclerosis.
    Joyce CW; Wagner EM; Basso F; Amar MJ; Freeman LA; Shamburek RD; Knapper CL; Syed J; Wu J; Vaisman BL; Fruchart-Najib J; Billings EM; Paigen B; Remaley AT; Santamarina-Fojo S; Brewer HB
    J Biol Chem; 2006 Nov; 281(44):33053-65. PubMed ID: 16928680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Macrophage expression of peroxisome proliferator-activated receptor-alpha reduces atherosclerosis in low-density lipoprotein receptor-deficient mice.
    Babaev VR; Ishiguro H; Ding L; Yancey PG; Dove DE; Kovacs WJ; Semenkovich CF; Fazio S; Linton MF
    Circulation; 2007 Sep; 116(12):1404-12. PubMed ID: 17724261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of Transcription Factor CREBH Accelerates Diet-Induced Atherosclerosis in Ldlr-/- Mice.
    Park JG; Xu X; Cho S; Lee AH
    Arterioscler Thromb Vasc Biol; 2016 Sep; 36(9):1772-81. PubMed ID: 27417587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reverse D4F, an apolipoprotein-AI mimetic peptide, inhibits atherosclerosis in ApoE-null mice.
    Qin S; Kamanna VS; Lai JH; Liu T; Ganji SH; Zhang L; Bachovchin WW; Kashyap ML
    J Cardiovasc Pharmacol Ther; 2012 Sep; 17(3):334-43. PubMed ID: 22308547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.